Intensive BP lowering reduces ED visit or hospitalization in HFpEF as well as HFrEF: Study MD Editorial Team17 Dec 2021 11:15 AM ISTIntensive BP treatment is associated with reduced acute decompensated heart failure (ADHF) events in the SPRINT (Systolic Blood Pressure Intervention...
Metformin improves outcomes in patients with HF and diabetes, finds Study Medha Baranwal16 Dec 2021 11:15 AM ISTUSA: A recent study involving older U.S. adults hospitalized for heart failure (HF) with comorbid diabetes found metformin initiation to be...
Novel Speech Recognizing App may help Predict HF by recognising fluid buildup in lungs: Study MD Bureau16 Dec 2021 9:00 AM ISTHeart failure (HF) is a progressive condition that affects approximately 26 million people worldwide. Most patients with HF present to the hospital...
Preeclampsia ups risk of heart failure in women: JACC Medha Baranwal15 Dec 2021 11:15 AM ISTUSA: A recent study in the Journal of the American College of Cardiology (JACC) has reported that women with pre-eclampsia/eclampsia are at...
Obesity measures strongly linked to heart failure risk in diabetes patients Medha Baranwal15 Dec 2021 10:45 AM ISTUSA: Higher waist circumference, fat mass, and body mass index (BMI) is strongly related to the risk of heart failure (HF) in older adults,...
Study explores new benefits of beta-blockers for heart health Medha Baranwal13 Dec 2021 9:00 AM ISTUK: A recent study published in the journal Circulation has suggested a beneficial effect of beta-blockers on the heart proteoglycan content....
Dr Reddys launches Valsartan in US Ruchika Sharma10 Dec 2021 3:26 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. has announced the launch of Valsartan Tablets, USP in the U.S. Market.The product is a therapeutic...
Parenteral iron followed by oral iron effective strategy for treating HFpEF: Study Medha Baranwal8 Dec 2021 9:00 AM ISTMumbai, Maharashtra: Parenteral iron carboxymaltose followed by oral iron supplementation is an effective treatment strategy in patients with heart...
Macitentan improves Cardiopulmonary structure and function in PAH patients MD Editorial Team7 Dec 2021 9:00 AM ISTA recent study found that Macitentan medication resulted in significant and clinically important improvements in right ventricular (RV) function and...
Quality of life in heart failure patients may be improved with Canagliflozin category Dr. Nandita Mohan5 Dec 2021 11:30 AM ISTThe CHIEF- HF trial results have shown that treating heart failure (HF) patients with canagliflozin a sodium-glucose cotransporter 2 (SGLT2)...
Sacubitril/valsartan decreases plasma NT-proBNP in HF patients with preserved ejection fraction: JAMA Medha Baranwal3 Dec 2021 9:00 AM ISTGermany: Sacubitril/valsartan significantly decreased plasma NT-proBNP levels at 12 weeks compared with standard medical therapies in patients with...
Empagliflozin safe in acute HF, improves 'Clinical Benefit' over time Dr. Nandita Mohan2 Dec 2021 10:42 AM ISTPatients with acute heart failure were safely started on empagliflozin a median of 3 days after hospitalization and were 36% more likely to...
